126 related articles for article (PubMed ID: 10705822)
41. [Cytogenetic and clinical study of myeloid leukemia].
Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
[TBL] [Abstract][Full Text] [Related]
42. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction.
Han JY; Theil KS
Cancer Genet Cytogenet; 2006 Feb; 165(1):70-4. PubMed ID: 16490599
[TBL] [Abstract][Full Text] [Related]
43. Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-Eo.
Macedo Silva ML; Raimondi SC; Abdelhay E; Gross M; Mkrtchyan H; de Figueiredo AF; Ribeiro RC; de Jesus Marques-Salles T; Sobral ES; Gerardin Land MP; Liehr T
Cancer Genet Cytogenet; 2008 Apr; 182(1):56-60. PubMed ID: 18328953
[TBL] [Abstract][Full Text] [Related]
44. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
[TBL] [Abstract][Full Text] [Related]
45. Minimal residual disease in acute myeloid leukaemia.
Liu Yin JA
Best Pract Res Clin Haematol; 2002 Mar; 15(1):119-35. PubMed ID: 11987920
[TBL] [Abstract][Full Text] [Related]
46. [Additional chromosomal abnormality of inv(16)(p13q22) to del(7)(q32) in a patient with acute myelomonocytic leukemia].
Ida T; Hashimoto S; Yano T; Sato N; Koike T
Rinsho Ketsueki; 2012 Mar; 53(3):347-51. PubMed ID: 22499053
[TBL] [Abstract][Full Text] [Related]
47. Molecular identification of CBFbeta-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses--a rare occurrence.
Ravandi F; Kadkol SS; Ridgeway J; Bruno A; Dodge C; Lindgren V
Leukemia; 2003 Sep; 17(9):1907-10. PubMed ID: 12970795
[No Abstract] [Full Text] [Related]
48. Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
Martinelli G; Buonamici S; Visani G; Malagola M; Piccaluga PP; Isidori A; Bosi C; Bonifazi F; Soverini S; Terragna C; Amabile M; Giannini B; Baccarani M
Leukemia; 2003 Mar; 17(3):650-1; author reply 651-2. PubMed ID: 12646962
[No Abstract] [Full Text] [Related]
49. Typical CBFbeta/MYH11 fusion due to insertion of the 3'-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22.
Aventín A; La Starza R; Nomdedéu J; Brunet S; Sierra J; Mecucci C
Cancer Genet Cytogenet; 2000 Dec; 123(2):137-9. PubMed ID: 11150605
[TBL] [Abstract][Full Text] [Related]
50. CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16.
Pirc-Danoewinata H; Dauwerse HG; König M; Chudoba I; Mitterbauer M; Jäger U; Breuning MH; Haas OA
Genes Chromosomes Cancer; 2000 Oct; 29(2):186-91. PubMed ID: 10959099
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
[TBL] [Abstract][Full Text] [Related]
52. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.
Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F
Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348
[TBL] [Abstract][Full Text] [Related]
53. Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party.
Langabeer SE; Walker H; Gale RE; Wheatley K; Burnett AK; Goldstone AH; Linch DC
Br J Haematol; 1997 Mar; 96(4):736-9. PubMed ID: 9074414
[TBL] [Abstract][Full Text] [Related]
54. The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB-MYH11-positive acute myeloid leukemia.
Van der Reijden BA; Massop M; Simons A; de Witte T; Breuning M; Jansen JH
Leukemia; 2010 Apr; 24(4):857-9. PubMed ID: 20072148
[No Abstract] [Full Text] [Related]
55. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
[TBL] [Abstract][Full Text] [Related]
56. Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
Van der Reijden BA; de Wit L; van der Poel S; Luiten EB; Lafage-Pochitaloff M; Dastugue N; Gabert J; Löwenberg B; Jansen JH
Hematol J; 2001; 2(3):206-9. PubMed ID: 11920247
[TBL] [Abstract][Full Text] [Related]
57. Molecular analysis of minimally differentiated acute myeloid leukemia with chromosome 16 inversion.
Sotomatsu M; Ogawa C; Shimoda M; Matsui A; Nakazawa S; Eguchi M; Morikawa A
Leuk Lymphoma; 1997 Jan; 24(3-4):319-25. PubMed ID: 9156661
[TBL] [Abstract][Full Text] [Related]
58. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.
van der Reijden BA; Dauwerse HG; Giles RH; Jagmohan-Changur S; Wijmenga C; Liu PP; Smit B; Wessels HW; Beverstock GC; Jotterand-Bellomo M; Martinet D; Mühlematter D; Lafage-Pochitaloff M; Gabert J; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Oncogene; 1999 Jan; 18(2):543-50. PubMed ID: 9927211
[TBL] [Abstract][Full Text] [Related]
59. Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.
Douet-Guilbert N; Chauveau A; Gueganic N; Guillerm G; Tous C; Le Bris MJ; Basinko A; Morel F; Ugo V; De Braekeleer M
Hematol Oncol; 2017 Sep; 35(3):385-389. PubMed ID: 28906004
[TBL] [Abstract][Full Text] [Related]
60. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Buonamici S; Ottaviani E; Testoni N; Montefusco V; Visani G; Bonifazi F; Amabile M; Terragna C; Ruggeri D; Piccaluga PP; Isidori A; Malagola M; Baccarani M; Tura S; Martinelli G
Blood; 2002 Jan; 99(2):443-9. PubMed ID: 11781223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
